Today's Daily Dose brings you news about FDA's mixed ruling on Achaogen's ZEMDRI; FDA panel recommending against approval of Pain Therapeutics' Remoxy ER; Starpharma's license agreement with Mundipharma and Amicus' regulatory and clinical development update.